2m 2m 2m 2m 2m 2m 2m
NEKTAR THERAPEUT (NKTR)
NASDAQ
$66.72+$1.02 (+1.54%)
Price as of Jun 23, 2026 4:10 PM EDT- $2.2BMarket Cap
- 588.68%1-Year Change
- BiotechnologyIndustry
NEKTAR THERAPEUT (NKTR)
$66.72+$1.02 (+1.54%)
NKTR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $65.70 | ||
Change | +$4.72 (+7.74%) | ||
Open | $62.30 | ||
High | $66.60 | ||
Low | $62.30 | ||
Previous Close | $60.98 | ||
Volume | 1,404,622 | ||
30-Day Average Volume | 990,335 | ||
1-Week Change | 7.45% | ||
1-Month Change | -1.37% | ||
1-Year Change | 588.68% | ||
3-Year Change | 696.36% | ||
5-Year Change | -73.73% | ||
Fundamentals | |||
Shares Outstanding | 33.8M | ||
Total Assets | $763.3M | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.1B | ||
Period: QTR TTM FY | |||
Revenue | $10.9M | ||
Net Income | -$44.9M | ||
Free Cash Flow | -$44.3M | ||
EBIT | -$44.8M | ||
EBITDA | -$44.7M | ||
Net Working Capital | $531.3M | ||
EPS | -$1.82 | ||
Enterprise Value/EBITDA | -46 | ||
Enterprise Value/Revenue | 191 | ||
P/B | 4 | ||
P/E | -36 | ||
PEG | 0 | ||
Price/Free Cash Flow | -50 | ||
Price/Operating Cash Flow | -50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 06/09/2025 | ||
Earnings & Revenue